Product Images Amlodipine Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Amlodipine Besylate NDC 50090-1021 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is an image of the structural formula for Amlodipine Besylate. - amlodusp 1
Figure 1 - Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo - amlodusp 2
This document seems to represent an analysis of some clinical trial. The trial probably involved a drug called Amlodipine. The document may present a time-to-event analysis in which an event rate of 0.0 is likely reported. Based on the P-value of 0.003 and Hazard Ratio of 0.691, it may be inferred that the treatment with Amlodipine had some impact on the event rate as compared to the control or placebo group. However, based on these values, it is unclear whether the effect was significant or not. Additionally, the table with the numbers and the "atrisk" notation suggest that there were some dropouts or censoring at different follow-up times. Overall, without more details, it is challenging to provide more specific and reliable information about this document.*
Figure 2 - Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups - amlodusp 3
This table displays the results of a clinical trial comparing the effect of Amlodipine versus Placebo. The table shows the number of patients in different age groups and gender who have been administered either Amlodipine or Placebo treatment. Patients have also been divided based on their baseline sitting systolic blood pressure (SBP) and whether they have any existing vessel disease. Additionally, patients have been divided based on whether they underwent PCI-stent placement or not. The table also displays the hazard ratio with a 95% confidence interval, indicating the efficacy of Amlodipine vs Placebo.*
Label Image - lbl500901020
Label Image - lbl500901021
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.